168 related articles for article (PubMed ID: 37532003)
1. Integrated PET/MRI With
Wu Y; Xu XJ; Sun X; Zhai H; Wang T; Cao XB; Xu Y
Behav Brain Res; 2023 Oct; 454():114609. PubMed ID: 37532003
[TBL] [Abstract][Full Text] [Related]
2. Metabolic correlates of levodopa response in Parkinson's disease.
Feigin A; Fukuda M; Dhawan V; Przedborski S; Jackson-Lewis V; Mentis MJ; Moeller JR; Eidelberg D
Neurology; 2001 Dec; 57(11):2083-8. PubMed ID: 11739830
[TBL] [Abstract][Full Text] [Related]
3. Chronic exposure to dopamine agonists affects the integrity of striatal D
Politis M; Wilson H; Wu K; Brooks DJ; Piccini P
Neuroimage Clin; 2017; 16():455-460. PubMed ID: 28879087
[TBL] [Abstract][Full Text] [Related]
4. Levodopa responsiveness in Parkinson's disease patients and white matter alterations in diffusion tensor imaging: a cross-sectional tract-based spatial statistics study.
Zhou W; Jiang J; Peng W; Zhou X; Du J; Mo L; Tan C; Liu X; Chen L
Neuroreport; 2021 May; 32(7):636-642. PubMed ID: 33850092
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and influencing factors of
Kangli F; Hongguang Z; Yinghua L; Xiaoxiao D; Yuyin D; Lulu G; Yi L; Zhihui S; Ying Z
Front Neurol; 2023; 14():1195577. PubMed ID: 37483437
[TBL] [Abstract][Full Text] [Related]
6. Brain activity alterations in patients with Parkinson's disease with cognitive impairment based on resting-state functional MRI.
Guo W; Jin W; Li N; Gao J; Wang J; Chang Y; Yin K; Chen Y; Zhang S; Wang T
Neurosci Lett; 2021 Mar; 747():135672. PubMed ID: 33515623
[TBL] [Abstract][Full Text] [Related]
7. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
Berding G; Odin P; Brooks DJ; Nikkhah G; Matthies C; Peschel T; Shing M; Kolbe H; van Den Hoff J; Fricke H; Dengler R; Samii M; Knapp WH
Mov Disord; 2001 Nov; 16(6):1014-22. PubMed ID: 11748732
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.
Nurmi E; Bergman J; Eskola O; Solin O; Hinkka SM; Sonninen P; Rinne JO
J Cereb Blood Flow Metab; 2000 Nov; 20(11):1604-9. PubMed ID: 11083235
[TBL] [Abstract][Full Text] [Related]
9. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
[TBL] [Abstract][Full Text] [Related]
10. Effects of STN-DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson's disease.
Luo G; Shi X; Jiang L; Wu L; Yi C; Xian W; Liu Y; Wen F; Qian H; Chen J; Fu X; Liu J; Zhang X; Chen L
Brain Behav; 2023 Aug; 13(8):e3172. PubMed ID: 37459244
[TBL] [Abstract][Full Text] [Related]
11. Effects of levodopa therapy on voxel-based degree centrality in Parkinson's disease.
Zhong M; Yang W; Huang B; Jiang W; Zhang X; Liu X; Wang L; Wang J; Zhao L; Zhang Y; Liu Y; Lin J; Huang R
Brain Imaging Behav; 2019 Oct; 13(5):1202-1219. PubMed ID: 30091020
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
[TBL] [Abstract][Full Text] [Related]
13. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
[TBL] [Abstract][Full Text] [Related]
14. Brain metabolic correlates of fatigue in Parkinson's disease: a PET study.
Zhang L; Li T; Yuan Y; Tong Q; Jiang S; Wang M; Wang J; Ding J; Xu Q; Zhang K
Int J Neurosci; 2018 Apr; 128(4):330-336. PubMed ID: 28918694
[TBL] [Abstract][Full Text] [Related]
15. Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
Wang X; Zhang J; Yuan Y; Li T; Zhang L; Ding J; Jiang S; Li J; Zhu L; Zhang K
Neurosci Lett; 2017 Jul; 653():202-207. PubMed ID: 28579485
[TBL] [Abstract][Full Text] [Related]
16. Motor activation in multiple system atrophy and Parkinson disease: a PET study.
Payoux P; Brefel-Courbon C; Ory-Magne F; Regragui W; Thalamas C; Balduyck S; Durif F; Azulay JP; Tison F; Blin O; Esquerre JP; Rascol O
Neurology; 2010 Sep; 75(13):1174-80. PubMed ID: 20876470
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors and Metabolism of Different Brain Regions by Positron Emission Tomography in Parkinson Disease with Disabling Dyskinesia.
Wei H; Zhou Y; Zhao J; Zhan L
Curr Neurovasc Res; 2019; 16(4):310-320. PubMed ID: 31622205
[TBL] [Abstract][Full Text] [Related]
18. FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.
Matthews DC; Lerman H; Lukic A; Andrews RD; Mirelman A; Wernick MN; Giladi N; Strother SC; Evans KC; Cedarbaum JM; Even-Sapir E
Neuroimage Clin; 2018; 20():572-579. PubMed ID: 30186761
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute levodopa challenge on resting cerebral blood flow in Parkinson's Disease patients assessed using pseudo-continuous arterial spin labeling.
Chen Y; Pressman P; Simuni T; Parrish TB; Gitelman DR
PeerJ; 2015; 3():e1381. PubMed ID: 26734502
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
